TheraNews Logo

Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD

hcplive|1/6/2026|Anxiety
Share this article:
Email

Early Week 2 Response Predicts Sustained Benefit with Adjunct Cariprazine in MDD

ONLY AVAILABLE IN PAID PLANS.


Originally reported by hcplive. Read more

Share this article:
Email

Related Articles

More stories about Anxiety